United Therapeutics (UTHR)
(Delayed Data from NSDQ)
$233.85 USD
-2.10 (-0.89%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $233.96 +0.11 (0.05%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth C Momentum C VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/1/24 |
---|---|
Current Quarter | 5.63 |
EPS Last Quarter | 4.36 |
Last EPS Surprise | 11.22% |
ABR | 1.50 |
Earnings ESP
|
0.91% |
---|---|
Current Year | 23.46 |
Next Year | 24.51 |
EPS (TTM) | 19.84 |
P/E (F1) | 10.06 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 627.72M | 655.61M | 2.62B | 2.81B |
# of Estimates | 7 | 7 | 7 | 7 |
High Estimate | 687.51M | 690.96M | 2.78B | 3.12B |
Low Estimate | 597.75M | 632.80M | 2.51B | 2.57B |
Year ago Sales | 506.90M | 596.50M | 2.33B | 2.62B |
Year over Year Growth Est. | 23.84% | 9.91% | 12.70% | 7.15% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 5.63 | 5.86 | 23.46 | 24.51 |
# of Estimates | 9 | 7 | 10 | 9 |
Most Recent Consensus | 5.93 | 6.32 | 25.91 | 26.98 |
High Estimate | 6.54 | 6.50 | 27.59 | 28.74 |
Low Estimate | 4.75 | 5.48 | 20.70 | 19.95 |
Year ago EPS | 4.86 | 5.24 | 19.81 | 23.46 |
Year over Year Growth Est. | 15.84% | 11.83% | 18.43% | 4.48% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 0 | 0 |
Up Last 60 Days | 3 | 2 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 0 | 1 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 5.63 | 5.86 | 23.46 | 24.51 |
7 Days Ago | 5.63 | 5.86 | 23.46 | 24.51 |
30 Days Ago | 5.63 | 5.85 | 23.46 | 24.52 |
60 Days Ago | 5.53 | 5.78 | 23.09 | 24.14 |
90 Days Ago | 5.01 | 5.58 | 22.01 | 23.98 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 5.68 | 6.32 | 23.31 | 23.47 |
Zacks Consensus Estimate | 5.63 | 5.86 | 23.46 | 24.51 |
Earnings ESP | 0.91% | 7.82% | -0.64% | -4.25% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 4.36 | 5.38 | 5.24 | 4.86 | NA |
Estimate | 3.92 | 4.89 | 4.41 | 4.35 | NA |
Difference | 0.44 | 0.49 | 0.83 | 0.51 | 0.57 |
Surprise | 11.22% | 10.02% | 18.82% | 11.72% | 12.95% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more